The use of remdesivir among pregnant women and associated clinical outcomes in mother and the child.

Ann Med Surg (Lond)

Department of Psychology, Faculty of Medical, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Published: May 2022

Introduction: and importance: Management of COVID19 has imposed a global challenge for hospitals, clinicians and patients. The use of medicines to treat clinical symptoms are likely to have adverse effects. COVID19 during pregnancy can be additional challenge since the CT scan cannot be performed in pregnant women.

Case Presentation: We reported the case series of use of remdesivir among 23 pregnant women. 5 of these women underwent cesarean section.

Clinical Discussion: Anticoagulants and dexamethasone were also used to treat these patients.

Conclusions: However, consultancy with the experienced and specialized doctor and timely management and monitoring of the mother and baby is required for effective outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047404PMC
http://dx.doi.org/10.1016/j.amsu.2022.103681DOI Listing

Publication Analysis

Top Keywords

remdesivir pregnant
8
pregnant women
8
women associated
4
associated clinical
4
clinical outcomes
4
outcomes mother
4
mother child
4
child introduction
4
introduction management
4
management covid19
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!